Laura Brege, Director at Pacira BioSciences, Inc. (PCRX), sold 2,100 shares at $48.70 ($102K) on 2020-06-05, disclosed to the SEC on 2020-06-08.
Seasonal sale ($102k) by Director — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |